AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Identification of stem cells as the cellular basis of prostate cancer provides therapeutic potential
Summary
Michael M. Shen, Ph.D..
Technology Benefits
Previously unidentified stem cell type in prostate endothelium Stem cell type is physiologically relevant to human prostate cancerExhibits oncogenic properties faithful to disease phenotype Patent information:Patent Pending (US20110045053)Tech Ventures Reference: IR 2624
Technology Application
Diagnosis of prostate cancer and prostate cancer riskPotential target for the development of therapeutics for prostate cancerBasis of in vitro high throughput assays for drug and biomarker development
Detailed Technology Description
Michael M. Shen, Ph.D..
Country/Region
USA
For more information, please click Here
